News
Plus Therapeutics (PSTV) announced positive data from a retrospective analysis of the CNSide Cerebrospinal Fluid, CSF, Assay Platform at the 2025 Society for Neuro-Oncology/American Society of ...
CNSide® may catalyze LM treatment initiation, allow physicians to adapt treatment with real time shifts in tumor biology, and enable personalized cancer therapy HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback